Antibiotics regulate the immune response in both presence and absence of lipopolysaccharide through modulation of Toll-like receptors, cytokine production and phagocytosis in vitro.

[1]  G. Kumar,et al.  Nationwide trends of severe sepsis in the 21st century (2000-2007). , 2011, Chest.

[2]  W. Wiersinga.  Current insights in sepsis: from pathogenesis to new treatment targets , 2011, Current opinion in critical care.

[3]  Michelle R. Lennartz,et al.  Protein Kinase C and Toll-Like Receptor Signaling , 2011, Enzyme research.

[4]  S. Akira,et al.  Pathogen Recognition by the Innate Immune System , 2011, International reviews of immunology.

[5]  S. Akira,et al.  The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors , 2010, Nature Immunology.

[6]  S. Akira,et al.  Protection from lethal Gram-negative bacterial sepsis by targeting Toll-like receptor 4 , 2009, Proceedings of the National Academy of Sciences.

[7]  S. Iho,et al.  General anaesthesia and TrkA mRNA in peripheral blood mononuclear cells. , 2008, European journal of anaesthesiology.

[8]  Peter A. Ward,et al.  Harmful molecular mechanisms in sepsis , 2008, Nature Reviews Immunology.

[9]  P. Tulkens,et al.  Contrasting effects of human THP-1 cell differentiation on levofloxacin and moxifloxacin intracellular accumulation and activity against Staphylococcus aureus and Listeria monocytogenes. , 2008, The Journal of antimicrobial chemotherapy.

[10]  C. Roussos,et al.  Effect of clarithromycin in patients with sepsis and ventilator-associated pneumonia. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  A. Hasebe,et al.  Resveratrol Modulates Phagocytosis of Bacteria through an NF-κB-Dependent Gene Program , 2007, Antimicrobial Agents and Chemotherapy.

[12]  A. Geballe,et al.  Gentamicin suppresses endotoxin-driven TNF-α production in human and mouse proximal tubule cells , 2007 .

[13]  L. Moldawer,et al.  ROLE OF TOLL-LIKE RECEPTORS IN THE DEVELOPMENT OF SEPSIS , 2007, Shock.

[14]  Thomas Unger,et al.  Quantitative real-time RT-PCR data analysis: current concepts and the novel “gene expression’s CT difference” formula , 2006, Journal of Molecular Medicine.

[15]  B. Bošnjak,et al.  Anti-inflammatory activity of azithromycin attenuates the effects of lipopolysaccharide administration in mice. , 2006, European journal of pharmacology.

[16]  H. Iwasaki,et al.  Erythromycin Differentially Inhibits Lipopolysaccharide- or Poly(I:C)-Induced but Not Peptidoglycan-Induced Activation of Human Monocyte-Derived Dendritic Cells1 , 2005, The Journal of Immunology.

[17]  A. Markewitz,et al.  Pro-inflammatory cytokines after different kinds of cardio-thoracic surgical procedures: is what we see what we know? , 2005, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[18]  O. Levy,et al.  Selective Impairment of TLR-Mediated Innate Immunity in Human Newborns: Neonatal Blood Plasma Reduces Monocyte TNF-α Induction by Bacterial Lipopeptides, Lipopolysaccharide, and Imiquimod, but Preserves the Response to R-8481 , 2004, The Journal of Immunology.

[19]  H. Blau,et al.  Anti-Inflammatory Effects of Moxifloxacin on Activated Human Monocytic Cells: Inhibition of NF-κB and Mitogen-Activated Protein Kinase Activation and of Synthesis of Proinflammatory Cytokines , 2004, Antimicrobial Agents and Chemotherapy.

[20]  R. Medzhitov,et al.  Regulation of Phagosome Maturation by Signals from Toll-Like Receptors , 2004, Science.

[21]  S. Ōmura,et al.  Molecular Mechanisms of Anti-Inflammatory Action of Erythromycin in Human Bronchial Epithelial Cells: Possible Role in the Signaling Pathway That Regulates Nuclear Factor-κB Activation , 2004, Antimicrobial Agents and Chemotherapy.

[22]  E. Giamarellos‐Bourboulis,et al.  Immunomodulatory Clarithromycin Treatment of Experimental Sepsis and Acute Pyelonephritis Caused by Multidrug-Resistant Pseudomonas aeruginosa , 2004, Antimicrobial Agents and Chemotherapy.

[23]  S. Calvano,et al.  Modulation of the Lipopolysaccharide Receptor Complex (CD14, TLR4, MD-2) and Toll-Like Receptor 2 in Systemic Inflammatory Response Syndrome-Positive Patients With and Without Infection: Relationship to Tolerance , 2003, Shock.

[24]  J. Kalbfleisch,et al.  Modulation of tissue Toll-like receptor 2 and 4 during the early phases of polymicrobial sepsis correlates with mortality. , 2003, Critical care medicine.

[25]  R. Vabulas,et al.  Cutting Edge: Myeloid Differentiation Factor 88 Deficiency Improves Resistance Against Sepsis Caused by Polymicrobial Infection1 , 2002, The Journal of Immunology.

[26]  M. Purswani,et al.  Effect of ciprofloxacin on lethal and sublethal challenge with endotoxin and on early cytokine responses in a murine in vivo model. , 2002, The Journal of antimicrobial chemotherapy.

[27]  K. Moore,et al.  Lipopolysaccharide Induces Scavenger Receptor A Expression in Mouse Macrophages: A Divergent Response Relative to Human THP-1 Monocyte/Macrophages1 , 2000, The Journal of Immunology.

[28]  M. Martin,et al.  Human cytokine responses to coronary artery bypass grafting with and without cardiopulmonary bypass. , 1999, The Annals of thoracic surgery.

[29]  E. Cillari,et al.  Intraperitoneal injection of tetracyclines protects mice from lethal endotoxemia downregulating inducible nitric oxide synthase in various organs and cytokine and nitrate secretion in blood , 1997, Antimicrobial agents and chemotherapy.

[30]  M. Potapnev,et al.  Different patterns of cytokine regulation of phagocytosis and bacterial killing by human neutrophils. , 1996, International journal of antimicrobial agents.

[31]  L. Shapira,et al.  Protection against endotoxic shock and lipopolysaccharide-induced local inflammation by tetracycline: correlation with inhibition of cytokine secretion , 1996, Infection and immunity.

[32]  G. Webster,et al.  Inhibition of a model of in vitro granuloma formation by tetracyclines and ciprofloxacin. Involvement of protein kinase C. , 1994, Archives of dermatology.

[33]  J. Weiler,et al.  Cytokine and complement levels in patients undergoing cardiopulmonary bypass. , 1993, The Journal of thoracic and cardiovascular surgery.

[34]  C. S. Park,et al.  A rapid and simple microfluorometric phagocytosis assay. , 1993, Journal of immunological methods.

[35]  W. van Oeveren,et al.  Endotoxin release and tumor necrosis factor formation during cardiopulmonary bypass. , 1992, The Annals of thoracic surgery.

[36]  M. Gougerot-Pocidalo,et al.  Ciprofloxacin treatment in vivo increases the ex vivo capacity of lipopolysaccharide‐stimulated human monocytes to produce IL‐1, IL‐6 and tumour necrosis factor‐alpha , 1991, Clinical and experimental immunology.

[37]  T. Tursz,et al.  Quinolone-induced differential modification of IL-1α and IL-1β production by LPS-stimulated human monocytes , 1990 .

[38]  P. Bonventre,et al.  Enhanced phagocytosis, killing, and serum sensitivity of Escherichia coli and Staphylococcus aureus treated with sub-MICs of imipenem , 1988, Antimicrobial Agents and Chemotherapy.

[39]  J. Petit,et al.  Influence of ciprofloxacin and piperacillin on interleukin-1 production by murine macrophages. , 1987, The Journal of antimicrobial chemotherapy.

[40]  Shigeru Tsuchiya,et al.  Establishment and characterization of a human acute monocytic leukemia cell line (THP‐1) , 1980, International journal of cancer.

[41]  T. van der Poll,et al.  Host-pathogen interactions in sepsis. , 2008, The Lancet. Infectious diseases.

[42]  R. Nau,et al.  Immunomodulatory properties of antibiotics. , 2008, Current molecular pharmacology.

[43]  James S. M. Tan,et al.  Nonantimicrobial effects of antibacterial agents. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[44]  U. Singh,et al.  Hyperglycemia Induces Monocytic Release of Interleukin-6 via Induction of Protein Kinase C-α and -β , 2005 .

[45]  T. Slifer,et al.  Effect of moxifloxacin on secretion of cytokines by human monocytes stimulated with lipopolysaccharide. , 2002, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[46]  L. Golub,et al.  Tetracyclines inhibit connective tissue breakdown: new therapeutic implications for an old family of drugs. , 1991, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.